| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3297097 | Gastroenterology | 2009 | 13 Pages |
Abstract
Delayed-release mesalamine 4.8 g/day (800-mg tablet) is efficacious and well-tolerated in patients with moderately active UC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
William J. Sandborn, Jaroslaw Regula, Brian G. Feagan, Elena Belousova, Njegica Jojic, Milan Lukas, Bruce Yacyshyn, Piotr Krzeski, Chyon-Hwa Yeh, Christi A. Messer, Stephen B. Hanauer,